Susquehanna Fundamental Investments, LLC Mustang Bio, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $104,987 - $136,728	-40,693 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.7 - $3.81 $39,430 - $55,641	-14,604 Reduced 26.41%	40,693 $135,000
Q1 2021 May 17, 2021	BUY	$3.02 - $5.16 $166,996 - $285,332	55,297 New	55,297 $184,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.